Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of May 13, 2025 • 6:31 PM ET

Date/Time Source News Release
05/08/2025 06:30 AM EDT ACCESS Newswire Broad-Spectrum Antiviral Drug NV-387 Cleared for Phase II Clinical Trial Application by the National Ethics Committee of the Democratic Republic of Congo
05/05/2025 06:30 AM EDT Newsfile NanoViricides, Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference, May 14th, NYC
04/29/2025 06:30 AM EDT ACCESS Newswire Measles is Likely to Become Endemic - NanoViricides Is Testing a Drug to Combat It
04/14/2025 06:30 AM EDT ACCESS Newswire Measles Outbreak Expands Begging for a Drug to Treat the Infection - NanoViricides Declares it is Ready to Fight the Outbreak
03/11/2025 07:30 AM EDT ACCESS Newswire NanoViricides Not Affected by Tariffs and Other Policies, Has Excellent Long Term Outlook, Stock-Price Decline Misguided, Explains the Company
03/04/2025 06:30 AM EST ACCESS Newswire Measles Outbreak: NV-387 Promises To Be An Effective Drug To Treat Patients; We are Ready To Work With HHS, Says NanoViricides President Dr. Anil Diwan
02/19/2025 06:30 AM EST ACCESS Newswire NanoViricides, Inc. Has Filed its Quarterly Report
02/11/2025 06:30 AM EST ACCESS Newswire NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape
01/29/2025 06:30 AM EST ACCESS Newswire NanoViricides to Present at the MicroCap Conference on Wednesday, January 29, 2025
01/27/2025 06:30 AM EST ACCESS Newswire NanoViricides Engages CRO for Phase II Clinical Trial
Page

Additional News

As of May 13, 2025 • 6:31 PM ET

Date/Time Source News Release
05/08/2025 09:45 AM EDT BioMedWire BioMedNewsBreaks - NanoViricides (NYSE American: NNVC) Clears Ethics Review for Phase II Mpox Trial in DRC 
05/05/2025 09:15 AM EDT InvestorBrandNetwork BioMedNewsBreaks - NanoViricides (NYSE American: NNVC) to Present at D. Boral Capital Inaugural Global Conference 
04/29/2025 10:18 AM EDT InvestorBrandNetwork BioMedNewsBreaks - NanoViricides (NYSE American: NNVC) Advances Measles Drug Development with Broad-Spectrum Antiviral NV-387 
03/12/2025 04:15 PM EDT Investing News Network Bird Flu Vaccine Stocks: 8 Companies Developing H5N1 Vaccines
03/11/2025 10:35 AM EDT InvestorBrandNetwork InvestorNewsBreaks - NanoViricides (NYSE American: NNVC) Highlights Antiviral Pipeline, Positions Stock as Market Hedge
03/04/2025 08:35 AM EST InvestorBrandNetwork InvestorNewsBreaks - NanoViricides (NYSE American: NNVC) Highlights NV-387 as Potential Measles Treatment Amid Outbreak
02/19/2025 11:43 AM EST InvestorBrandNetwork BioMedNewsBreaks - NanoViricides (NYSE American: NNVC) Reports Financials, Advances NV-387 Antiviral Trials
02/19/2025 06:36 AM EST SeekingAlpha NanoViricides GAAP EPS of -$0.14
02/11/2025 08:30 AM EST InvestorBrandNetwork InvestorNewsBreaks - NanoViricides (NYSE American: NNVC) Claims NV-387 Ready to Combat Bird Flu
01/29/2025 08:30 AM EST InvestorBrandNetwork InvestorNewsBreaks - NanoViricides (NYSE American: NNVC) Showcases NV-387's Broad-Spectrum Antiviral Potential at MicroCap Conference
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.